Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:43:17 EDT Fri 17 Apr 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:NGEN - Nervgen Pharma Corp. - https://www.nervgen.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NGEN - VDEFUNCT5.15    8.49  2.57Mar 16Apr 1315 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-04-13 07:45C:NGEN5.15News ReleaseNervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference
2026-04-07 07:30C:NGEN5.15News ReleaseNervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia
2026-03-31 07:45C:NGEN5.15News ReleaseNervGen Pharma Reports Full Year 2025 Financial Results and Provides Business Updates
2026-03-13 20:26C:NGEN5.00Shares Delisted from TSX-VNervgen Pharma prospectus offering, delisting
2026-03-12 16:15C:NGEN5.26News ReleaseNervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange
2026-03-04 16:52C:NGEN5.89News ReleaseNervgen appoints Ruff as officer, McSherry as senior VP
2026-02-18 07:30C:NGEN5.55News ReleaseNervGen Pharma to Participate at Upcoming Investor Conferences
2026-02-12 22:00C:NGEN5.60News ReleaseNervgen Pharma CFO Adams to retire March 15
2026-02-11 07:00C:NGEN5.40News ReleaseNervGen Pharma to Present at Unite2Fight Paralysis' 20th Annual Science and Advocacy Symposium
2026-02-09 16:41C:NGEN5.35News ReleaseNervgen appoints Rogers as president, CEO
2026-01-20 07:00C:NGEN7.31News ReleaseNervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
2026-01-08 12:16C:NGEN7.82News ReleaseNervgen begins trading on Nasdaq
2025-12-17 23:55C:NGEN6.00News ReleaseNervgen files Form F-10 registration statement with SEC
2025-12-15 21:39C:NGEN5.80MiscellaneousNervgen Pharma warrants repriced
2025-12-12 20:13C:NGEN6.00News ReleaseNervgen Pharma plans to amend warrants
2025-11-27 18:08C:NGEN5.31Private PlacementNervgen Pharma 4,785,674-share private placement
2025-11-24 07:25C:NGEN4.00SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-24 07:25C:NGEN4.00SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-24 07:06C:NGEN4.00News ReleaseNervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates
2025-11-24 07:02C:NGEN4.00News ReleaseNervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury